secwatch.observer — SEC 8-K summary
======================================

Issuer:     Perspective Therapeutics, Inc. (CATX)
CIK:        0000728387
Form:       8-K
Filed at:   2023-02-06T23:59:59+00:00
Accession:  0001437749-23-002543
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 1.02, 5.02, 2.01, 3.02, 5.03, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Isoray closes all-stock merger with Viewpoint; Spoor named CEO, Woods Chair
---------------------------------------------------------------------------

- Completed all-stock merger with Viewpoint; issued 136.5M shares (49% of pro forma) at 3.1642 exchange ratio.
- New CEO Thijs Spoor (ex-Viewpoint CEO) appointed; Lori Woods becomes Chairperson of the Board.
- Woods receives $504K severance, accelerated vesting of 1,007,498 stock options under separation agreement.
- Board expanded to five: Woods (Chair), Spoor, Morich, Williamson, and McCormick.
- Fiscal year changed from June 30 to December 31; transition Form 10-KT to be filed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/728387/000143774923002543/0001437749-23-002543-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/728387/000143774923002543/isr20230204_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-23-002543

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer